Health FITNESS & NUTRITION HEALTH CARE POLICY MENTAL HEALTH & BEHAVIOR. Mike Hutchings/Reuters ED PRINT REPRINTS SAVE SHARE

Similar documents
Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

"GUARDING AGAINST TUBERCULOSIS AS A FIRST RESPONDER"

Health. What do brain surgeons know about cellphone safety that the rest of us don t?

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

The emerging threat of multidrug resistant TB: Global and local challenges and solutions

"GUARDING AGAINST TUBERCULOSIS IN HEALTHCARE FACILITIES"

"GUARDING AGAINST TUBERCULOSIS IN INSTITUTIONAL FACILITIES"

Primer on Tuberculosis (TB) in the United States

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

What Is TB? 388 How TB Is Spread 388 How to Know if a Person Has TB 389 How to Treat TB 389 Resistance to TB medicines 390

What Drug Treatment Centers Can do to Prevent Tuberculosis

Drug-resistant Tuberculosis

Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite

MULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic

Global epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos

PANDEMIC INFLUENZA PREPAREDNESS: STATE CHALLENGES

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

SGI Cell Biology Unit. Transparencies and Student Sheets

Antimicrobial resistance Fact sheet N 194 Updated April 2014

Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics

Global, National, Regional

News English.com Ready-to-use ESL / EFL Lessons

Descriptive Epidemiology Project: Tuberculosis in the. United States. MPH 510: Applied Epidemiology. Summer A 2014

Global, National, Regional

SHARE SELECTION. Click here to print. Thursday, Nov 6th AM 46 F 10AM 44 F 5 Day Forecast. By Associated Press

Latest Funding Trends in AIDS Response

Evolution of XDR-TB. A. Willem Sturm Interim Director K-RITH Nelson R Mandela School of Medicine University of KwaZulu-Natal

TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.

Replaces: 02/11/16. Formulated: 7/95 EMPLOYEE TB TESTING

Coughs, Colds & Pneumonia

Chapter 7 Tuberculosis (TB)

Addressing TB in a High HIV Prevalence Setting in Rural South Africa: the 3Is

Evaluating the Economic Consequences of Avian Influenza (1) Andrew Burns, Dominique van der Mensbrugghe, Hans Timmer (2)

The WHO END-TB Strategy

The NALC Health Benefit Plan HBR Report

Influenza: The Threat of a Pandemic

Fundamental Principles about Bioterrorism

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

Deadly E. coli strikes Europe

TUBERCULOSIS (TB) PREVENTION AND TREATMENT

Plagues and People & The Economist Exploring AIDS Origins & Predicting Viral Epidemics. Presented by Alexis Fields

An Uncured Disease. By: Katie Farley. A disease so prominent, so recently discovered and so deadly has

Ebola in Congo not yet a global health emergency, WHO says 18 May 2018, by Saleh Mwanamilongo

HIV AIDS and Other Infectious Diseases

Questions and Answers About

Kenya Perspectives. Post-2015 Development Agenda. Tuberculosis

YOU ARE NOT ALONE Health and Treatment for HIV Positive Young Men of Color

Diagnosis of drug resistant TB

Drug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye

What You Need to Know About. TB Infection TUBERCULOSIS

Pandemic Preparedness: Pigs, Poultry, and People versus Plans, Products, and Practice

TB Transmission, Pathogenesis & Infection Control

TB and Respiratory Protection

Communicating About Ebola: A Guide for Leaders. Produced by the Pan American Health Organization

Swine flu deaths expected to rise

Tuberculosis in Alameda County, 2009

Turning Off the Spigot Reducing Nosocomial Drug Resistant TB. Edward A. Nardell, MD Harvard Medical School/PIH Brigham & Women s Hospital

COMMUNITY SYSTEMS TOOLBOX COMMUNITY SYSTEMS STRENGTHENING. Increasing access to quality health and social services. Building strong communities.

CHAPTER 3: DEFINITION OF TERMS

U.S. and British troops head to West Africa to help fight Ebola virus

Proposed Regs.pdf

Self-Study Modules on Tuberculosis

Occupational Infections: Risks for the Anesthesiologist

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

Controlling TB in the era of HIV

What is tuberculosis? What causes tuberculosis?

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine

For many of the world's poor, drinking water can be deadly

1-2 December 2015 Geneva, Switzerland. Anticipating emerging infectious disease epidemics

Questions and Answers About

All you need to know about Tuberculosis

Ecumenical Ebola Response

H1N1-A (Swine flu) and Seasonal Influenza

Labor, Health and Human Services & Education Labor, Health and Human Services & Education

PREVALENCE OF HIV INFECTION AND RISK FACTORS OF TUBERCULIN INFECTION AMONG HOUSEHOLD CONTACTS IN AN HIV EPIDEMIC AREA: CHIANG RAI PROVINCE, THAILAND

Transmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos

People left behind: Sex workers

The incidence of HIV/AIDS, tuberculosis and other infectious diseases is higher on this continent than on any other.

News English.com Ready-to-use ESL / EFL Lessons

TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks

Disease-causing organisms

AOHS Global Health. Unit 1, Lesson 3. Communicable Disease

Infection Prevention and Control Annual Education Authored by: Infection Prevention and Control Department

Show the truth. Picture warnings save lives. WORLD NO TOBACCO DAY 31 MAY 2009

From VOA Learning English, this is Science in the News. I m Mario Ritter.

Overview of the WHO policy on TB Infection Control and practical aspects and implementation tools for effective IC measures in Health facilities

COSTA RICA KEY. Public health is the study of how diseases spread in a population and the measures used to control them.

3 patients died in a Pasadena outbreak possibly caused by medical scopes

Tobacco OR Health. Tara Singh Bam, PhD, MPH

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area

WHO: Forum Issue #02 Student Officer Position:

University of Colorado Denver. Pandemic Preparedness and Response Plan. April 30, 2009

Hello, and welcome to As It Is, from VOA Learning English. I m Steve Ember in Washington.

BOSTWANA KEY. Controlling the Pandemic: Public Health Focus

Okinawa, Toyako, and Beyond: Progress on Health and Development

Women In Science Scholars Annual Meeting Highlights October 3, 2016

AN AIRLINE EXPERIENCE OF PUBLIC HEALTH EMERGENCIES DR NIGEL DOWDALL HEAD OF AVIATION HEALTH UNIT UK CIVIL AVIATION AUTHORITY

THE Price of a Pandemic 2017

Transcription:

Page 1 of 5 HOME PAGE MY TIMES TODAY'S PAPER VIDEO MOST POPULAR TIMES TOPICS Free 14-Day Trial Welcome, susannadodgson Member Center Log Out Health Health All NYT WORLD U.S. N.Y. / REGION BUSINESS TECHNOLOGY SCIENCE HEALTH SPORTS OPINION ARTS STYLE TRAVEL JOBS REAL ESTATE AUTOS FITNESS & NUTRITION HEALTH CARE POLICY MENTAL HEALTH & BEHAVIOR THE DOCTOR'S WORLD Rise of a Deadly TB Reveals a Global System in Crisis Next Article in Health (1 of 10)» A tuberculosis patient in rural Tugela Ferry, South Africa. By LAWRENCE K. ALTMAN, M.D. Published: March 20, 2007 LOS ANGELES The spread of a particularly virulent form of tuberculosis in South Africa illustrates a breakdown in the global program that is supposed to keep the disease, one of the world s deadliest, under control. Mike Hutchings/Reuters E-MAIL PRINT REPRINTS SAVE SHARE The program was intended to detect tuberculosis cases, make sure patients were taking their antibiotics, test patients for resistance to those drugs and monitor the spread of the disease. Karin Weyer/South African Medical Research Council During a tuberculosis outbreak in South Africa, patients often infected one another in clinics not designed to allow a quick quarantine. But international tuberculosis experts say the system is in deep trouble for an array of reasons: misuse of antibiotics; other bad medical practices, like failing to segregate highrisk patients in hospitals and clinics; and cuts in government spending for such basics as adequate supplies of drugs and laboratories to do the testing. Such factors have led to the rise of drug-resistant tuberculosis bacteria, a menace the world has only begun to appreciate. Mycobacterium tuberculosis, the microbe that causes the disease, was discovered 125 years ago this month. Today, the bacteria infect 8.8 million people a year and cause 1.6 million deaths. They are spread in tiny droplets when patients cough. MOST POPULAR E-MAILED BLOGGED SEARCHED Tuberculosis is curable, as long as the bacteria are susceptible to antibiotics. It becomes deadlier when it attacks people who are also infected with H.I.V., the AIDS virus. And when the tuberculosis bacteria become extremely drug-resistant, the death rate soars. That was the case in Tugela Ferry, a rural town in KwaZulu-Natal province in South Africa, when an outbreak of extremely drug-resistant tuberculosis XDR-TB for short 1. Pet Food Is Recalled After Link to Animal Deaths 2. The Critical Years: For Teachers, Middle School Is Test of Wills 3. Partner Adopted by an Heiress Stakes Her Claim 4. Buying With Help From Mom and Dad 5. Paul Krugman: Don t Cry for Reagan 6. The Barefoot Impresario

Page 2 of 5 killed 52 of its 53 victims, all of whom were also infected with H.I.V. The outbreak was detected in 2005, but it did not receive international attention until it was reported at the international AIDS meeting in Toronto last August. The World Health Organization calls the extremely drug-resistant form a grave public health threat because of its potential explosiveness among the millions of H.I.V.-infected people in poor countries. It seems to be a lesser threat among people who do not have H.I.V., though it could be dangerous to the millions with weakened immune systems from treatment for cancer and other diseases. XDR-TB is defined as tuberculosis that is resistant to the two most important antituberculosis drugs (isoniazid and rifampin), along with two other drugs: a member of the fluoroquinolone class and at least one of three others (capreomycin, kanamycin and amikacin). 7. In Shriner Spending, a Blurry Line of Giving 8. Editorial Observer: It Wasn t Just a Bad Idea. It May Have Been Against the Law. 9. The Women s War 10. Basics: Guidelines for Using a Cellphone Abroad Go to Complete List» nytimes.com/business A step lower on the resistance scale is a form of the disease called MDR-TB, for multidrug-resistant tuberculosis. An outbreak of that form struck in New York City in the early 1990s, and cost at least $1 billion in emergency measures to control and manage tuberculosis patients. Everything you need to know before filing your taxes Also in Business: Tax tips that can save you money Which tax software program does the best job on its own? A guide to the gift tax Experts say the tuberculosis outbreak in South Africa is the deadliest one that they can recall. Although South African officials, who have known about the outbreak for a year, promised a prompt and full investigation, even experts there acknowledge that efforts are lagging. Unfortunately, we do not know much more than a year ago mainly because a systematic survey in each of the provinces has not yet started, Dr. Karin Weyer of the South African Medical Research Council told the Conference on Retroviruses and Opportunistic Infections here recently. Dr. Weyer said in an interview that she had hoped that rapid surveys and screening tests would have been completed by now to show better the geographic extent of the disease. Using statistics from recent years, Dr. Weyer said her team estimated that 6,000 new cases of multidrug-resistant tuberculosis occurred in South Africa each year and that the rate of treatment failure was about 10 percent. Assuming that most failures were due to the extremely drug-resistant form, a conservative estimate is 600 cases of XDR-TB in her country each year, Dr. Weyer said. In data that her team examined, about 85 percent of patients infected with XDR-TB and H.I.V. died, she said. The fatality rate in H.I.V.-negative patients seemed lower, but could not be determined until they complete long-term therapy. What is known is that the deadly XDR-TB strain has been found in more than 40 hospitals in all nine provinces of South Africa, she said. The rest of sub-saharan Africa is at risk, she went on, because control of airborne infection is either totally inadequate or even absent in virtually all of those countries. The outbreak is not limited to Africa. Dr. Paul Nunn, a tuberculosis expert at the World Health Organization, told the meeting here that one or more cases of XDR-TB had been found in at least 28 countries. Extrapolating from data about the multidrug-resistant form of tuberculosis, Dr. Nunn estimated that two-thirds of the XDR-TB cases were from China, India and Russia.

Page 3 of 5 The recipe for spreading the disease is the same throughout the world: inappropriate use of antibiotics. When first-line drugs fail to kill the disease, Dr. Nunn said, doctors turn to a second group of drugs that are less widely used, and, they hope, more effective because the bacteria have not had a chance to become resistant to them. The little evidence we have suggests that this is not so much spread of resistant strains, but the creation of similar patterns of resistance in different strains around the world, Dr. Nunn said, because the drugs used are more or less the same everywhere, and unfortunately, so are the defects in the performance of TB control. South Africa has more laboratories to test tuberculosis strains for susceptibility to firstand second-line drugs than other sub-saharan countries, Dr. Nunn said. He added, Most African countries do not have a laboratory capable of carrying out first-line drug susceptibility tests, let alone for second-line drugs, which is technically more demanding. For those and other reasons, like a lack of doctors, health officials say they fear that tuberculosis may be spreading silently in other countries. Experiments performed years ago have led some experts to speculate that drug-resistant tuberculosis bacteria are poorly transmissible. But that theory seems weakened by new studies from South African researchers working with colleagues from Harvard and the Centers for Disease Control and Prevention in Atlanta. The researchers put caged guinea pigs in a ventilation stream leading from rooms housing patients with multidrug-resistant tuberculosis and possibly the extremely drugresistant form. Skin tests showed that 80 percent of the animals were newly infected after four months, Dr. Weyer said. XDR-TB may be just as infectious as regular tuberculosis and may be highly transmissible. And that is worrisome, Dr. Weyer said, because most public health facilities in the developing world lack airborne infection control procedures. How the guinea pig findings translate to humans is uncertain because other studies have not been done or completed. In one study, South African researchers tested 1,694 relatives and friends who had contact with 386 XDR-TB patients identified in Tugela Ferry. Among those contacts, only 12 cases of multidrug-resistant tuberculosis were found, and none of XDR-TB, Dr. Weyer reported. The findings suggested that significant spread was not occurring in the community. But it was too soon to know, because even a drug-susceptible tuberculosis infection usually remains silent for years before it causes illness, Dr. Weyer said. This is the kind of exercise that we would like to see happening in other areas and for longer periods to get a better understanding of the risk of transmission and getting sick, Dr. Weyer said. The risk that the initial tuberculosis infection will progress to illness is compounded at 10 percent a year for those with H.I.V., compared with a lifetime risk of 10 percent among those who do not have the virus. In medical journals and at scientific meetings, some doctors in South Africa and elsewhere have advocated enforced confinement of XDR-TB patients. But civil liberties aside, many experts say, these advocates have not thought through the practical aspects of such isolations. Enforced isolation is much more difficult to implement than one

Page 4 of 5 would think, Dr. Weyer said. Because XDR-TB is believed to be incurable, such patients could be detained for life or until they die. All the while, infected patients may spread the disease to others. Moreover, the disease is an occupational hazard for the health workers caring for patients; 4 were included among the 53 in the Tugela Ferry outbreak. Two additional cases in health workers were identified later. So Dr. Weyer raised these questions, among others: What facilities would be used? Who would volunteer to take care of XDR-TB patients? How would these workers be protected? And without getting permission, how would health officials legally detect the many health workers who are infected with H.I.V.? She offered no answers. And earlier this month, as if to illustrate the logistical hazards of caring for XDR-TB patients, 100 people walked out of a hospital in East London, South Africa, after paramedics wearing head-to-toe protection brought in eight patients with the disease. Some South African hospitals are using engineering- and infection-control practices, like installing ultraviolet lights to kill tuberculosis microbes. Management studies show that health care facilities must be redesigned to prevent unnecessary contact between tuberculosis and H.I.V. patients in crowded clinics, X-ray departments, waiting lines and other areas, Dr. Weyer said. On April 1, she said, South Africa plans to start field-testing 40,000 patients to determine the effectiveness of two new rapid tests to detect drug-resistant tuberculosis, and whether the results will lead to improved treatment outcomes. Elsewhere, researchers will test 60,000 patients under the direction of the Foundation for Innovative New Diagnostics in Geneva, Dr. Weyer said. About 20 experimental drugs are being tested. But even if one is found effective in largescale trials, it is unlikely to be marketed for a decade. Next Article in Health (1 of 10)» Need to know more? 50% off home delivery of The Times. Tips To find reference information about the words used in this article, double-click on any word, phrase or name. A new window will open with a dictionary definition or encyclopedia entry. Past Coverage World Briefing Africa: South Africa: Patients Flee TB Patients (March 7, 2007) World Briefing Africa: South Africa: Lethal TB Strain Kills 5 More (February 9, 2007) Virulent TB in South Africa May Imperil Millions Without Quick Action, Experts Warn (January 28, 2007) Detention Is Urged For African TB Cases (January 23, 2007) Related Searches Tuberculosis South Africa Epidemics Medicine and Health INSIDE NYTIMES.COM HEALTH» ARTS» U.S.» N.Y. / REGION»

Page 5 of 5 Tracing the Cigarette s Path From Sexy to Deadly Communist Party USA Gives Its Past to N.Y.U. Across the Country, Worry Over Pet Food America s Top ebay Town Araton: Where Are Black Ball Players? Home World U.S. N.Y. / Region Business Technology Science Health Sports Opinion Arts Style Travel Jobs Real Estate Automobiles Back to Top Copyright 2007 The New York Times Company Privacy Policy Search Corrections RSS First Look Help Contact Us Work for Us Site Map